“a favorable trend”

However some RCTs detected a favorable trend towards 20-30% relative risk reduction mortality in certain patient subsets.

Although no head-to-head trials have directly compared these regimens, atezolizumab plus bevacizumab has demonstrated a favorable trend in the overall response rate (30.0% vs. 20.1%), median overall survival (19.2 vs. 16.4 months), and progression-free survival (6.9 vs. 3.8 months).

However, the 5-year survival rate rises to 60% when surgical and radiation therapy are combined, indicating a favorable trend when surgery is added [ 136 ].

Although the difference did not reach statistical significance, a favorable trend toward improved wound closure was observed in the GPP@VP NIR group.

Biochemically, the 12-week rhythmic walking intervention led to significant reductions in TC, LDLC, TG, and the TG/HDLC ratio, with a favorable trend in the TC/HDLC ratio.

The pooled analysis for all-cause mortality showed a favorable trend (OR 0.63), however the confidence interval (0.33–1.20) crossed unity, indicating the data remains underpowered to confirm statistical significance for mortality as a stand-alone endpoint.

In this study, the music intervention was also associated with a favorable trend toward lower rates of PONV (27.6% vs. 47.9%) and insomnia (23.4% vs. 41.6%); however, these differences did not reach statistical significance.

Conclusions: A favorable trend is observed with respect to the mean LOE as well as the number of level 2 studies and RCTs over time.

For the first time, we confirmed how G-Rh2 changed the biometabolic behavior of tumors by regulating PDK4, leading to a favorable trend towards normal apoptotic programming.

The results indicated a favorable trend for prophylaxis, with a significantly lower joint ABR found in the intervention group [RR = 0.09; 95% CI: (0.06, 0.14)] as compared to the control group.

Neflamapimod (target class: inflammation), a p38α kinase inhibitor, demonstrated a favorable trend for NRGN and decreased CSF levels of pTau181 and tTau in comparison to a placebo.

Regarding the predisposition towards engaging in other leisure activities (LAs) offered in the analyzed municipality, there is also a favorable trend towards them (81.29%).

Regarding survival, a favorable trend was found for the experimental arm; however, with a median follow-up of 20.6 months, the EFS outcomes were still immature (HR 0.76; 95% CI, 0.40 to 1.44) [ 63 ]. 3.3.

Moreover, a favorable trend for EFS was revealed, although statistical significance was not already reached [ 99 ].

While our study did not find statistically significant associations between TILs and these parameters, we observed a favorable trend toward higher TILs in cases with smaller tumors and no nodal metastasis.

Our analysis did not find a significant difference between RD and LF groups, although a favorable trend was observed in LF patients in terms of VAS scores for back pain.

Patient self-assessment demonstrated a favorable trend toward greater clinical benefit with buffy coat PRP.

Moreover, the improvement in RL min is accompanied by a reduction in the matching thickness, which is a favorable trend for high‐temperature EMW absorbers.

Excitingly, this translated into a favorable trend toward better functional outcomes.

45 , 46 Our study results showed that while outcomes of concurrent chemoradiotherapy were comparable to systemic treatment alone (ORR: 78% vs 69%, mPFS: 13.4 vs 9.2 months), the concurrent radiotherapy group demonstrated a favorable trend in hazard ratio (HR = 1.78, 95% CI: 0.70–4.54) suggesting better prognosis, though the difference did not reach statistical significance ( p = 0.23).

Additionally, the pembrolizumab arm also showed a favorable trend in EFS (HR = 0.63 [95% CI 0.43-0.93]).

Although not statistically significant, the proportion of patients achieving TMPG 3 and cTFC also showed a favorable trend in the IC group compared with that in the IV group (Fig. 1 ).

5 Conclusions This prospective clinical case series suggests that the adjunctive use of advanced platelet‐rich fibrin (A‐PRF) in the surgical management of MRONJ is associated with a favorable trend toward mucosal healing; however, in the absence of a control group, definitive conclusions regarding its efficacy cannot be drawn.

Despite these methodological limitations, the results suggest a favorable trend in clinical markers.

While measuring homophily depends on the traits of the actors under consideration, a favorable trend toward homophily in scientific collaboration has been highlighted in the literature when assessed by gender.